Barclays maintains an 'Overweight' on Quest Diagnostics (DGX); Perspectives on Celera: Time Will Tell
Go back to Barclays maintains an 'Overweight' on Quest Diagnostics (DGX); Perspectives on Celera: Time Will Tell| Celera Corporation (NASDAQ: CRA) | Delayed: 8.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.04 | 52 Week High | $8.42 | |||
| Open | $0.66 | 52 Week Low | $5.35 | |||
| Day High | $8.04 | P/E | N/A | |||
| Day Low | $8.04 | EPS | $-0.20 | |||
| Volume | 44,710 | |||||
| Quest Diagnostics (NYSE: DGX) | Delayed: 244.39 +3.09 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $241.30 | 52 Week High | $86.85 | |||
| Open | $240.33 | 52 Week Low | $59.66 | |||
| Day High | $244.70 | P/E | 46.02 | |||
| Day Low | $239.43 | EPS | $5.31 | |||
| Volume | 1,263,230 | |||||
